Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.33 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22118872 | 0.86 | TSHR (0.36) | PNPRNASEH1ALDH1A1TSHRMEN1 | |
| SCHEMBL22118854 | 0.85 | RNASEH1 (0.34) | PNPRNASEH1 | |
| SCHEMBL22119381 | 0.85 | RNASEH1 (0.34) | PNPRNASEH1 | |
| Hydrochloric Acid SCHEMBL22119087 | 0.83 | PNP (0.32) | PNPRNASEH1 | |
| SCHEMBL22118865 | 0.83 | PNP (0.33) | PNP | |
| SCHEMBL22118859 | 0.83 | RNASEH1 (0.33) | PNPRNASEH1 | |
| SCHEMBL22118816 | 0.82 | PNP (0.31) | PNP | |
| SCHEMBL22118896 | 0.79 | PNP (0.31) | PNPRNASEH1 | |
| SCHEMBL22118878 | 0.79 | SIGMAR1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL22118809 | 0.78 | RNASEH1 (0.33) | PNPRNASEH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897645-A1 | DNA POLYMERASE IIIC INHIBITORS AND USE THEREOF | Acurx Pharmaceuticals, LLC (US) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020132174-A1 | DNA POLYMERASE IIIC INHIBITORS AND USE THEREOF | ACURX PHARMACEUTICALS, LLC (US) | 2020-06-25 | — | — | WO | disclosed |